Enzo Biochem Inc
ENZBDelisted Apr 7, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000316253
Enzo Biochem Inc was delisted on Apr 7, 2025; its insiders filed their last Form 4 on Aug 20, 2025; 41 institutions reported holding it in 13F filings for Q1 2025, worth $4.96M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Enzo Biochem Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 72 | 65 | −7 |
| Shares | 24.2M | 23.4M | −732.1K (−3.0%) |
| Value | $76.6M | $82.9M | +$6.33M (+8.3%) |
New holders (6)
Institutions that held Enzo Biochem Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Belvedere Trading LLC | 25,998 | $86.0K | 0.02% |
| Raymond James & Associates | 17,058 | $60.0K | 0.00% |
| Algert Global LLC | 13,712 | $49.0K | 0.01% |
| Neuberger Berman Group LLC | 10,836 | $38.0K | 0.00% |
| BDO Wealth Advisors, LLC | 5,000 | $18.0K | 0.00% |
| Private Capital Group, LLC | 1,250 | $4.00K | 0.00% |
Sold out (13)
Institutions that held Enzo Biochem Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Tibra Equities Europe Ltd | 111,000 | $352.0K |
| Jane Street Group, LLC | 77,317 | $245.0K |
| Jump Financial, LLC | 39,000 | $124.0K |
| Marshall Wace, LLP | 28,909 | $92.0K |
| Corsair Capital Management, L.P. | 16,911 | $54.0K |
| XTX Topco Ltd | 14,737 | $47.0K |
| Boothbay Fund Management, LLC | 13,900 | $44.0K |
| ExodusPoint Capital Management, LP | 13,166 | $42.0K |
| Assenagon Asset Management S.A. | 11,793 | $37.0K |
| Panagora Asset Management Inc | 2,135 | $7.00K |
| Advisory Services Network, LLC | 500 | $2.00K |
| New York State Common Retirement Fund | 349 | $1.00K |
| Citigroup Inc | 78 | $0 |